Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Neurosurgery. Case Lessons|March 23, 2026
Treatment strategies for relapsed medulloblastoma in the pediatric population: illustrative caseZoe Lockhart, Vanessa Y Ruiz, Zoe King, et al.
Neuro-Oncology Advances|March 12, 2024
DNA methylation landscapes in DIPG reveal methylome variability that can be modified pharmacologicallyAshley R Tetens, Allison M Martin, Antje Arnold, et al.
Neuro-Oncology|April 27, 2017
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based studyDaniel N Cagney, Allison M Martin, Paul J Catalano, et al.
JAMA Oncology|March 17, 2017
Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based StudyAllison M Martin, Daniel N Cagney, Paul J Catalano, et al.
Journal of Neuro-Oncology|February 5, 2019
Local control after brain-directed radiation in patients with cystic versus solid brain metastasesRachel H Brigell, Daniel N Cagney, Allison M Martin, et al.
Science Translational Medicine|December 23, 2016
Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBMDimitrios Mathios, Jennifer E Kim, Antonella Mangraviti, et al.
Breast Cancer Research and Treatment|April 15, 2019
Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastasesDaniel N Cagney, Nayan Lamba, Sofia Montoya, et al.
Cancers|August 10, 2024
VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in MedulloblastomaNatalia Muñoz Perez, Juliana M Pensabene, Phillip M Galbo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 6, 2018
Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiationDaniel N Cagney, Allison M Martin, Paul J Catalano, et al.
International Journal of Cancer|September 25, 2018
Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastomaSarah Harris-Bookman, Dimitrios Mathios, Allison M Martin, et al.
Pageof 3